Equivalent immunogenicity across three RSVpreF vaccine lots in healthy adults 18–49 years of age: Results of a randomized phase 3 study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Equivalent immunogenicity across three RSVpreF vaccine lots in healthy adults 18–49 years of age: Results of a randomized phase 3 study

Published:2024-05 Issue:13 Volume:42 Page:3172-3179
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Baker Jeffrey,Aliabadi Negar,Munjal Iona,Jiang Qin,Feng Ye,Brock Linda G.,Cooper David,Anderson Annaliesa S.,Swanson Kena A.,Gruber William C.,Gurtman Alejandra

Funder

Pfizer Inc

Publisher

Elsevier BV

Reference30 articles.

1. Strategic priorities for respiratory syncytial virus (RSV) vaccine development;Anderson;Vaccine,2013

2. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age;Hall;Pediatrics,2013

3. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study;Shi;Lancet,2017

4. The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: a systematic review;Colosia;PLoS One,2017

5. Low levels of RSV testing among adults hospitalized for lower respiratory tract infection in the United States;Rozenbaum;Infect Dis Ther,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maternal Vaccination for the Prevention of Infantile RSV Disease: An Overview of the Authorized, In-Progress, and Rejected Vaccine Candidates;Vaccines;2024-08-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP